tiprankstipranks
Trending News
More News >
Addus Homecare (ADUS)
NASDAQ:ADUS
Advertisement

Addus Homecare (ADUS) AI Stock Analysis

Compare
343 Followers

Top Page

ADUS

Addus Homecare

(NASDAQ:ADUS)

Select Model
Select Model
Select Model
Outperform 76 (OpenAI - 4o)
Rating:76Outperform
Price Target:
$126.00
▲(7.38% Upside)
Addus Homecare's strong financial performance and positive earnings call sentiment are the primary drivers of its stock score. While the technical analysis suggests a neutral trend, the company's strategic focus and growth potential provide a positive outlook. Valuation is reasonable, supporting the overall positive assessment.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for services and effective market penetration, supporting long-term business expansion.
Strategic Acquisitions
Strategic acquisitions enhance market presence and service capabilities, driving future growth and competitive advantage.
Cash Flow Management
Strong cash flow management ensures financial stability and supports future investments, enhancing long-term operational resilience.
Negative Factors
Home Health Segment Challenges
Declining revenue in the Home Health segment suggests operational challenges that may hinder growth in this area.
CMS Proposed Payment Rule Concerns
Potential reduction in Medicare payments could impact revenue and service availability, posing a risk to financial performance.
Labor Challenges in Clinical Hiring
Labor shortages in clinical hiring may affect service delivery and operational efficiency, impacting long-term growth.

Addus Homecare (ADUS) vs. SPDR S&P 500 ETF (SPY)

Addus Homecare Business Overview & Revenue Model

Company DescriptionAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
How the Company Makes MoneyAddus Homecare generates revenue primarily through the provision of home care services, which are reimbursed by various payers, including Medicare, Medicaid, and private insurance companies. The company's revenue model is predominantly fee-for-service, where they bill for the hours of care provided to clients. Key revenue streams include personal care services, skilled nursing services, and therapy services. Additionally, partnerships with healthcare providers and payers enhance their service offerings and patient access, contributing to the overall growth and stability of their earnings. As the demand for home care services continues to rise due to an aging population and a shift towards home-based care, Addus Homecare's revenue potential is bolstered by these market trends.

Addus Homecare Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 03, 2025
Earnings Call Sentiment Positive
The earnings call highlighted strong revenue and earnings growth, successful debt reduction, and strategic acquisitions, primarily driven by the Personal Care and Hospice segments. However, challenges were noted in the Home Health segment and concerns over the CMS proposed payment rule impacting future service availability were expressed. Overall, the company showed positive momentum with some areas needing attention.
Q2-2025 Updates
Positive Updates
Strong Revenue Growth
Total revenue for the second quarter of 2025 was $349.4 million, an increase of 21.8% compared to the second quarter of 2024.
Increased Earnings Per Share
Adjusted earnings per share increased by 10.4% to $1.49 from $1.35 in the second quarter of 2024.
Adjusted EBITDA Growth
Adjusted EBITDA was $43.9 million, up 24.5% compared to the second quarter of 2024.
Debt Reduction
The company reduced bank debt by $30 million, leaving a balance of $173 million at quarter end.
Acquisition of Helping Hands Home Care
Addus HomeCare closed on its acquisition of Helping Hands Home Care, expanding its market coverage in Pennsylvania.
Personal Care Segment Performance
Personal Care segment showed a same-store revenue growth of 7.4% compared to the second quarter of 2024.
Hospice Segment Growth
Hospice same-store revenue increased by 10% compared to the same quarter of 2024.
Reimbursement Rate Increases
Illinois and Texas finalized budgets with reimbursement rate increases for personal care services, expected to add significant annualized revenue.
Negative Updates
Home Health Segment Challenges
Home health same-store revenue decreased by 6% compared to the same quarter of 2024.
CMS Proposed Payment Rule Concerns
The proposed rule projects a 6.4% reduction in Medicare payments to home health agencies, which could impact service availability.
Labor Challenges in Clinical Hiring
Continued challenges in clinical hiring, particularly in certain geographic areas.
Disappointment with Hospice Rate Increase
The 2.6% increase for hospice providers does not fully reflect the rising cost of care.
Company Guidance
During the Addus HomeCare second quarter 2025 earnings call, the company reported a 21.8% increase in total revenue, reaching $349.4 million, compared to $286.9 million in the same quarter of 2024. This growth was accompanied by a rise in adjusted earnings per share to $1.49, a 10.4% increase from the previous year's $1.35. Adjusted EBITDA also saw a significant boost, climbing 24.5% to $43.9 million. The company highlighted strong cash flows, ending the quarter with approximately $91 million in cash on hand and reducing bank debt by $30 million to $173 million. Key operational metrics included 105 hires per business day in the Personal Care segment and a 7.4% same-store revenue growth in the Personal Care segment. Addus also discussed anticipated revenue increases due to reimbursement rate hikes in Illinois and Texas, projecting an additional $17.5 million and $17.7 million in annualized revenue, respectively. The company remains focused on strategic acquisitions, recently closing the acquisition of Helping Hands Home Care, enhancing its presence in Western Pennsylvania. Despite challenges in clinical hiring, Addus expressed confidence in its home-based care services and its potential for continued growth.

Addus Homecare Financial Statement Overview

Summary
Addus Homecare demonstrates strong financial performance with consistent revenue growth, stable profitability margins, and a solid balance sheet. The company effectively manages its cash flows, supporting future growth and debt repayment.
Income Statement
85
Very Positive
Addus Homecare demonstrates strong revenue growth with a consistent increase over the past years. The Gross Profit Margin and Net Profit Margin are stable, reflecting efficient operations and profitability. EBIT and EBITDA margins also show a healthy margin, indicating effective cost management. Overall, the income statement reflects robust financial health.
Balance Sheet
78
Positive
The company's balance sheet is solid with a moderate Debt-to-Equity Ratio, indicating a balanced approach to leveraging. Return on Equity is commendable, showing the company's ability to generate profits from shareholders' equity. The Equity Ratio is strong, suggesting a stable financial structure with low risk of over-leverage.
Cash Flow
82
Very Positive
Operating cash flows are strong and consistently cover net income, demonstrating efficient cash management. Free Cash Flow has shown a positive trend, indicating the company's ability to generate cash after accounting for capital expenditures. This positions the company well for future investments or debt repayment.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.21B1.15B1.06B951.12M864.50M764.77M
Gross Profit394.52M375.02M339.88M299.74M269.85M226.24M
EBITDA127.53M120.61M106.56M83.14M80.70M57.18M
Net Income79.00M73.60M62.52M46.02M45.13M33.13M
Balance Sheet
Total Assets1.41B1.41B1.02B937.99M947.59M892.58M
Cash, Cash Equivalents and Short-Term Investments96.95M98.91M64.79M79.96M168.90M145.08M
Total Debt250.80M273.13M175.18M178.05M263.55M239.67M
Total Liabilities412.20M442.14M317.73M304.45M373.24M373.91M
Stockholders Equity995.38M970.49M706.69M633.54M574.34M518.68M
Cash Flow
Free Cash Flow90.12M110.38M102.79M96.81M34.84M102.58M
Operating Cash Flow96.70M116.43M112.25M105.11M39.49M109.41M
Investing Cash Flow-354.24M-354.61M-119.24M-106.59M-42.02M-214.24M
Financing Cash Flow277.77M272.30M-8.18M-87.45M26.34M138.19M

Addus Homecare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price117.34
Price Trends
50DMA
112.20
Positive
100DMA
112.27
Positive
200DMA
111.74
Positive
Market Momentum
MACD
0.66
Negative
RSI
60.22
Neutral
STOCH
86.75
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADUS, the sentiment is Positive. The current price of 117.34 is above the 20-day moving average (MA) of 112.77, above the 50-day MA of 112.20, and above the 200-day MA of 111.74, indicating a bullish trend. The MACD of 0.66 indicates Negative momentum. The RSI at 60.22 is Neutral, neither overbought nor oversold. The STOCH value of 86.75 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADUS.

Addus Homecare Risk Analysis

Addus Homecare disclosed 31 risk factors in its most recent earnings report. Addus Homecare reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Addus Homecare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$2.16B25.888.54%14.29%7.85%
74
Outperform
877.87M32.488.56%30.58%24.86%
69
Neutral
1.96B18.2310.26%1.95%25.19%13.44%
68
Neutral
1.48B57.503.90%51.97%-64.10%
40
Underperform
451.72M-1.37-77.19%10.12%-29.12%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADUS
Addus Homecare
117.34
-15.69
-11.79%
NHC
National Healthcare
126.41
2.89
2.34%
ASTH
Astrana Health
29.68
-28.26
-48.77%
PNTG
Pennant Group
25.40
-10.30
-28.85%
AGL
Agilon Health
1.09
-2.84
-72.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 20, 2025